2016_Head & Neck COURSE BOOK
Loco regional control and p16 ‐
St. I-II p16+ 90% St. III-IV p16+
St. III-IV p16- St I II . - -
p16 57%
DAHANCA 2000‐2013, curative intent RT, oropharynx patients with known p16 status (n=1163)
Made with FlippingBook
Loco regional control and p16 ‐
St. I-II p16+ 90% St. III-IV p16+
St. III-IV p16- St I II . - -
p16 57%
DAHANCA 2000‐2013, curative intent RT, oropharynx patients with known p16 status (n=1163)
Made with FlippingBook